The article focuses on the study of Vitamin D fortified probiotic yoghurt and NAFLD. Topics discussed include Non-alcoholic fatty liver disease (NAGLFD) is an inflammatory disease; Inflammation not only exacerbates NAFLD but can also lead to adverse systemic effects such as cardiovascular diseases; and Modification of inflammation is considered a new therapeutic target for NAFLD.